High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
出版年份 2020 全文链接
标题
High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-08-29
DOI
10.1093/schbul/sbaa136
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde
- (2020) Michael Maes et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia
- (2019) Michael Maes et al. NEUROTOXICITY RESEARCH
- Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation
- (2019) Wook-Jin Chae et al. DIFFERENTIATION
- The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
- (2019) Chutima Roomruangwong et al. MOLECULAR NEUROBIOLOGY
- Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns
- (2018) Ryan D Ross et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients
- (2018) Sunee Sirivichayakul et al. NEUROTOXICITY RESEARCH
- A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions.
- (2018) Sunee Sirivichayakul et al. CNS & Neurological Disorders-Drug Targets
- In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype
- (2018) Michael Maes et al. NEUROTOXICITY RESEARCH
- HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
- (2016) Barry W. Festoff et al. Journal of Neuroinflammation
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia
- (2016) Haozhe Li et al. PSYCHIATRY RESEARCH
- Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
- (2016) Stefan Leucht et al. SCHIZOPHRENIA BULLETIN
- High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
- (2015) Cristiano Noto et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products
- (2011) Andréy Mazarati et al. EXPERIMENTAL NEUROLOGY
- Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population
- (2010) Branko Aleksic et al. SCHIZOPHRENIA RESEARCH
- Increased serum levels of CCL11/eotaxin in schizophrenia
- (2007) Antonio Lucio Teixeira et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More